Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Patrick Griffin soars in as ImmusanT CMO

This article was originally published in Scrip

Executive Summary

Privately-held biotech ImmusanT has hired Dr Patrick Griffin chief medical officer and senior vice-president of development. Dr Griffin joins ImmusanT from Sanofi's immuno-inflammation therapeutic strategy unit where he was most recently head of external innovation. He originally joined Sanofi in 2005 as senior director of clinical development.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC016698

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel